Catalyst
Slingshot members are tracking this event:
Data from Part B of GW Pharma's (GWPH) Phase 2 Study Evaluating CBDV (GWP42006) in Partial-Onset Epilepsy due H1 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 21, 2018
Occurred Source:
http://ir.gwpharm.com/news-releases/news-release-details/gw-pharmaceuticals-announces-preliminary-results-phase-2a-study
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2 Data, Gwp42006, Epilepsy, Cbdv, Partial-onset Epilepsy, Inadequately Controlled Focal Seizures
